title: Well-differentiated carcinoma of the thyroid.
abstract: Thyroid cancer will be diagnosed in more than 20,000 individuals in the United States in 2002. Approximately 16,000 of these patients will be women. During the same year, an estimated 1300 deaths from thyroid cancer are expected. The various types of thyroid cancer include papillary carcinoma, follicular carcinoma, Hurthle cell carcinoma, medullary carcinoma, anaplastic carcinoma, and thyroid lymphoma. Papillary, follicular, and Hurthle cell carcinoma are considered well-differentiated thyroid cancers and constitute the focus of this article.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Slot 543, Little Rock, AR 72205-7199, USA.
authors.forename: Ryan T
authors.initials: RT
authors.lastname: Boone
authors.forename: Chun-Yang
authors.initials: CY
authors.lastname: Fan
authors.forename: Ehab Y
authors.initials: EY
authors.lastname: Hanna
mesh_terms: D018263:Adenocarcinoma, Follicular / Q000175:diagnosis* / Q000628:therapy*; D000231:Adenocarcinoma, Papillary / Q000175:diagnosis* / Q000628:therapy*; D018249:Adenoma, Oxyphilic / Q000175:diagnosis* / Q000628:therapy*; D000328:Adult; D001707:Biopsy, Needle; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D011247:Pregnancy; D011379:Prognosis; D013964:Thyroid Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D013965:Thyroidectomy